Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Moccia

Showing results (1-10 of 221) with videos related to

Pageof 23
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 16, 2020
Teleconsultation will replace most face-to-face interactions in the multiple sclerosis clinic - NoMarcello Moccia
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 3, 2025
Clinical commentary to gender-affirming interventions and prognosis in multiple sclerosisMarcello Moccia
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 30, 2021
Demyelinating disorders following COVID-19 vaccinationMarcello Moccia
Ebiomedicine|November 24, 2018
Time to reconsider urate: Neuroprotective potential may prevail on cardiovascular risk in animal models and clinical trialsMartina Petruzzo, Marcello Moccia
Neuroimaging Clinics of North America|April 11, 2017
Molecular and Metabolic Imaging in Multiple SclerosisMarcello Moccia, Olga Ciccarelli
Neurology|December 22, 2025
Can Once-Yearly Rituximab Dosing Be "Enough" for Most People With Relapsing Multiple Sclerosis?Marcello Moccia, Elizabeth Silbermann
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 20, 2023
Mobile health interventions in multiple sclerosis: Bringing empowerment into clinical practiceIsabel Rovisco Monteiro, Marcello Moccia
Journal of the Neurological Sciences|February 15, 2026
Authors response to Comment on "Plasma neurofilament light chain to evaluate response during cladribine treatment in multiple sclerosis"Valerio Nicolella, Daniela Terracciano, Marcello Moccia
Stroke|May 29, 2014
Letter by Moccia et al regarding article, "Archetypal Arg169Cys mutation in NOTCH3 does not drive the pathogenesis in cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy via a loss-of-function mechanism"Marcello Moccia, Silvana Penco, Paolo Barone
Nature Reviews. Neurology|September 17, 2025
Implementation of the 2024 revision of the McDonald criteria for multiple sclerosisMarcello Moccia, Olga Ciccarelli, Alan Thompson
Pageof 23

Showing results (1-10 of 221) with videos related to

Sort By:
Pageof 23
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 16, 2020
Teleconsultation will replace most face-to-face interactions in the multiple sclerosis clinic - NoMarcello Moccia
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 3, 2025
Clinical commentary to gender-affirming interventions and prognosis in multiple sclerosisMarcello Moccia
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 30, 2021
Demyelinating disorders following COVID-19 vaccinationMarcello Moccia
Ebiomedicine|November 24, 2018
Time to reconsider urate: Neuroprotective potential may prevail on cardiovascular risk in animal models and clinical trialsMartina Petruzzo, Marcello Moccia
Neuroimaging Clinics of North America|April 11, 2017
Molecular and Metabolic Imaging in Multiple SclerosisMarcello Moccia, Olga Ciccarelli
Neurology|December 22, 2025
Can Once-Yearly Rituximab Dosing Be "Enough" for Most People With Relapsing Multiple Sclerosis?Marcello Moccia, Elizabeth Silbermann
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 20, 2023
Mobile health interventions in multiple sclerosis: Bringing empowerment into clinical practiceIsabel Rovisco Monteiro, Marcello Moccia
Journal of the Neurological Sciences|February 15, 2026
Authors response to Comment on "Plasma neurofilament light chain to evaluate response during cladribine treatment in multiple sclerosis"Valerio Nicolella, Daniela Terracciano, Marcello Moccia
Stroke|May 29, 2014
Letter by Moccia et al regarding article, "Archetypal Arg169Cys mutation in NOTCH3 does not drive the pathogenesis in cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy via a loss-of-function mechanism"Marcello Moccia, Silvana Penco, Paolo Barone
Nature Reviews. Neurology|September 17, 2025
Implementation of the 2024 revision of the McDonald criteria for multiple sclerosisMarcello Moccia, Olga Ciccarelli, Alan Thompson
Pageof 23